🚀 Apply for £10k+ grants with our Startup Launch Kit
shadow shadow shadow shadow shadow
    Country
    Opportunity Status
    Funding Instrument Type
    Category
    Clear

    Accelerating Product Excellence in Innovation and for Clinical Adoption (APEx) (U24 Clinical Trial Not Allowed)

    NOT-DE-26-006

    Scott Verbridge, PhD National Institute of Dental and Craniofacial Research (NIDCR)

    Opening date 27 May 2025, 12:00AM

    Closing date N/A

    Funding Opportunity Number: NOT-DE-26-006

    Opportunity Category: Discretionary

    CFDA Number(s): 93.121 -- Oral Diseases and Disorders Research

    Cost Sharing or Matching Requirement: No

    Posted Date: May 27, 2025 12:00:00 AM EDT

    Closing Date: N/A

    Eligible Applicants: Independent school districts,Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education,County governments,Public and State controlled institutions of higher education,Small businesses,State governments,For profit organizations other than small businesses,Native American tribal governments (Federally recognized),Public housing authorities/Indian housing authorities,Native American tribal organizations (other than Federally recognized tribal governments),Private institutions of higher education

    Description:

    The National Institute of Dental and Craniofacial Research (NIDCR), with other NIH Institutes and Centers (ICs), intends to publish a Notice of Funding Opportunity (NOFO) to solicit applications for the formation of extramural Resource Centers (RCs) whose purpose is to support promising strategies and products for tissue engineering and regenerative medicine (TE/RM). RCs will capitalize on their available clinical, scientific, industrial, regulatory, and commercialization expertise to select, support, and guide Interdisciplinary Translational Projects (ITPs) in the areas of therapeutics (including adult stem cell-based treatments), sensors, and diagnostics. This funding cycle will support the RC infrastructure and ITPs in their validation, manufacturing, and preclinical testing of the most promising products, which may include, but are not limited to products for detecting and/or treating tissue damage caused by congenital defects, traumatic injury, or chronic disease. Products that support early detection of chronic pathologies, monitoring of validated biomarkers of health and/or disease, as well as approaches to reduce or prevent resulting chronic damage, are especially encouraged. The outcome of APEx will be TE/RM products with their regulatory approvals in place for first-in-human studies, along with associated clinical study protocols, and synthesis and manufacturing protocols ready for initiation of clinical trials. Applications are not being solicited at this time. Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects. This NOFO will utilize the U24 activity code. Investigators with expertise and insights in TE/RM are encouraged to begin to consider applying for this new NOFO.

    We use cookies and similar technologies that are necessary to operate the website.Please read our cookie policy.

    We use cookies and similar technologies that are necessary to operate the website. Additional cookies are only used with your consent. We use the additional cookies to perform analyses of website usage and to check marketing measures for their efficiency. These analyses are carried out to provide you with a better user experience on the website. You are free to give, deny, or withdraw your consent at any time by using the "cookie settings" link at the bottom of each page. You can consent to our use of cookies by clicking "Agree". For more information about what information is collected and how it is shared with our partners, please read our cookie policy.

    • Required to run the website
    • Monitoring website usage and optimizing the user experience
    • Evaluation of marketing actions
    • Storage of your preferences from previous visits
    • Collecting user feedback to improve our website
    • Recording of your interests in order to provide customised content and offers
    Cookie Settings Accept